✦ LIBER ✦

The feasibility of using cognitive behaviour therapy for depression associated with Parkinson's disease: A literature review

✍ Scribed by Kristina Cole; Frances L. Vaughan

Book ID: 116820072
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 124 KB
Volume: 11
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2005.03.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of depression and anxiety in P

Treatment of depression and anxiety in Parkinson's Disease: A pilot study using group cognitive behavioural therapy

✍ Farah Feeney; Sarah Egan; Dr. Natalie Gasson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

A waitlist-controlled trial of group cog

A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease

✍ Troeung, Lakkhina; Egan, Sarah J; Gasson, Natalie 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 275 KB

Impact of physical therapy for Parkinson

Impact of physical therapy for Parkinson's disease: A critical review of the literature

✍ G. Kwakkel; C.J.T. de Goede; E.E.H. van Wegen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Cognitive behavioural therapy for the tr

Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis

✍ Hind, Daniel; Cotter, Jack; Thake, Anna; Bradburn, Mike; Cooper, Cindy; Isaac, C 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 880 KB

Risk of valvular heart disease associate

Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson’s disease: a systematic review

✍ Malcolm Steiger; W. Jost; F. Grandas; G. Van Camp 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 238 KB

The risk of venous thromboembolic diseas

The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma : A systematic review

✍ Steven R. Deitcher; Marcelo P. V. Gomes 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Background: Tamoxifen therapy for patients with breast carcinoma is perceived as an independent risk factor for venous thromboembolic events (vte), but the risk associated with other adjuvant therapies is less well recognized. ## Methods: The authors conducted a computerized pubmed literature